ACI
Archean Chemical Industries Limited
Marine and specialty chemicals producer diversifying into semiconductors and energy storage
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
archeanchemicals.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Archean Chemical Industries (ACI) produces bromine, industrial salt and bromine derivatives from coastal brine fields in India and sells mostly to export customers.
Company snapshot
22ndBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓Debt-to-equity of 0.24x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 290 Cr | 413 Cr | 284 Cr | 213 Cr | 240 Cr | 242 Cr | 346 Cr | 292 Cr | 233 Cr | 255 Cr | 301 Cr | 327 Cr |
| Operating expenses (approx.) | 195 Cr | 267 Cr | 197 Cr | 141 Cr | 166 Cr | 162 Cr | 257 Cr | 214 Cr | 171 Cr | 200 Cr | 257 Cr | 260 Cr |
| EBITDA | 95 Cr | 145 Cr | 87 Cr | 71 Cr | 75 Cr | 80 Cr | 88 Cr | 78 Cr | 63 Cr | 54 Cr | 44 Cr | 67 Cr |
| OPM % | 32.9% | 35.2% | 30.7% | 33.5% | 31.1% | 33.0% | 25.5% | 26.7% | 26.8% | 21.4% | 14.5% | 20.6% |
| Other income | 11 Cr | 9 Cr | 12 Cr | 10 Cr | 11 Cr | 9 Cr | 8 Cr | 8 Cr | 6 Cr | 7 Cr | 5 Cr | 6 Cr |
| Interest | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 3 Cr | 3 Cr | 0.29 Cr | 5 Cr | 6 Cr | 4 Cr | 10 Cr | 5 Cr |
| Depreciation | 18 Cr | 18 Cr | 18 Cr | 19 Cr | 19 Cr | 20 Cr | 21 Cr | 23 Cr | 24 Cr | 24 Cr | 23 Cr | 23 Cr |
| Profit before tax | 87 Cr | 135 Cr | 80 Cr | 61 Cr | 23 Cr | 66 Cr | 75 Cr | 58 Cr | 40 Cr | 33 Cr | 16 Cr | 44 Cr |
| Tax % | 24.4% | 24.9% | 27.8% | 26.0% | 30.9% | 27.3% | 28.0% | 30.8% | 27.2% | 28.0% | 22.9% | 31.4% |
| Net profit | 66 Cr | 102 Cr | 58 Cr | 45 Cr | 16 Cr | 48 Cr | 54 Cr | 40 Cr | 29 Cr | 24 Cr | 12 Cr | 30 Cr |
| EPS (₹) | ₹5.36 | ₹8.24 | ₹4.65 | ₹3.64 | ₹1.28 | ₹3.89 | ₹4.33 | ₹3.25 | ₹2.36 | ₹1.92 | ₹1.13 | ₹2.48 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 608 Cr | 1,130 Cr | 1,441 Cr | 1,330 Cr | 1,041 Cr | 1,081 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 460 Cr | 663 Cr | 807 Cr | 867 Cr | 727 Cr | 842 Cr | Sign in free for the trailing twelve months |
| EBITDA | 148 Cr | 467 Cr | 634 Cr | 463 Cr | 314 Cr | 239 Cr | Sign in free for the trailing twelve months |
| OPM % | 24.3% | 41.3% | 44.0% | 34.8% | 30.2% | 22.1% | Sign in free for the trailing twelve months |
| Other income | 9 Cr | 12 Cr | 43 Cr | 43 Cr | 37 Cr | 27 Cr | Sign in free for the trailing twelve months |
| Interest | 122 Cr | 162 Cr | 97 Cr | 8 Cr | 8 Cr | 26 Cr | Sign in free for the trailing twelve months |
| Depreciation | 52 Cr | 67 Cr | 69 Cr | 70 Cr | 79 Cr | 93 Cr | Sign in free for the trailing twelve months |
| Profit before tax | -17 Cr | 251 Cr | 512 Cr | 427 Cr | 224 Cr | 147 Cr | Sign in free for the trailing twelve months |
| Tax % | -117.0% | 24.9% | 25.2% | 25.3% | 27.5% | 28.3% | Sign in free for the trailing twelve months |
| Net profit | -36 Cr | 189 Cr | 383 Cr | 319 Cr | 162 Cr | 105 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹-3.51 | ₹18.26 | ₹34.66 | ₹25.90 | ₹13.13 | ₹8.66 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | 0.0% | 17.4% | 7.6% | 35.1% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 19 Cr | 19 Cr | 25 Cr | 25 Cr | 25 Cr | 25 Cr |
| Reserves | -13 Cr | 242 Cr | 1,406 Cr | 1,677 Cr | 1,839 Cr | 1,910 Cr |
| Borrowings | 857 Cr | 845 Cr | 21 Cr | 60 Cr | 178 Cr | 466 Cr |
| Other liabilities | 565 Cr | 424 Cr | 303 Cr | 295 Cr | 351 Cr | 265 Cr |
| Total liabilities | 1,429 Cr | 1,530 Cr | 1,755 Cr | 2,056 Cr | 2,393 Cr | 2,665 Cr |
| Fixed assets (net) | 882 Cr | 1,045 Cr | 1,110 Cr | 1,160 Cr | 1,378 Cr | 1,383 Cr |
| CWIP | 158 Cr | 17 Cr | 36 Cr | 46 Cr | 65 Cr | 72 Cr |
| Investments | 47 Cr | 11 Cr | 210 Cr | 350 Cr | 339 Cr | 257 Cr |
| Loans & advances | — | — | 0.43 Cr | 0.43 Cr | 0.56 Cr | 0.54 Cr |
| Inventories | 99 Cr | 121 Cr | 168 Cr | 127 Cr | 168 Cr | 215 Cr |
| Trade receivables | 44 Cr | 153 Cr | 118 Cr | 156 Cr | 165 Cr | 127 Cr |
| Cash & bank | 24 Cr | 12 Cr | 6 Cr | 45 Cr | 41 Cr | 41 Cr |
| Other assets | 173 Cr | 170 Cr | 107 Cr | 171 Cr | 238 Cr | 569 Cr |
| Total assets | 1,429 Cr | 1,530 Cr | 1,755 Cr | 2,056 Cr | 2,393 Cr | 2,665 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | 148 Cr | 315 Cr | 496 Cr | 379 Cr | 176 Cr | 140 Cr |
| Cash from investing | -197 Cr | -110 Cr | -290 Cr | -307 Cr | -246 Cr | -293 Cr |
| Cash from financing | 26 Cr | -224 Cr | -212 Cr | -33 Cr | 65 Cr | 154 Cr |
| Net cash flow | -23 Cr | -19 Cr | -6 Cr | 40 Cr | -5 Cr | 0.69 Cr |
| Free cash flow (OCF − Capex) | -4 Cr | 218 Cr | 396 Cr | 248 Cr | -87 Cr | -243 Cr |
Ratios
| Metric | Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 12.2% | 37.3% | 41.9% | 24.7% | 11.4% | 7.2% |
| ROE % | -605.1% | 72.2% | 26.7% | 18.7% | 8.7% | 5.5% |
| Debtor days | 27 | 49 | 30 | 43 | 58 | 43 |
| Inventory days | 1443 | 980 | 1336 | 976 | 972 | 892 |
| Days payable | 2440 | 911 | 761 | 766 | 608 | 437 |
| Cash conversion cycle | -970 | 118 | 605 | 254 | 422 | 498 |
| OCF / EBITDA % | 99.7% | 67.3% | 78.2% | 82.0% | 56.1% | 58.5% |
| OCF / EBITDA % (3 years) | — | — | — | 76.1% | 74.5% | 68.5% |
| Debt / equity | 143.21 | 3.24 | 0.02 | 0.03 | 0.10 | 0.24 |
| Current ratio | 1.03 | 2.27 | 3.35 | 5.38 | 3.50 | 1.21 |
| Net debt / EBITDA | 5.63 | 1.78 | 0.02 | 0.03 | 0.44 | 1.78 |